A Study to Evaluate Efficacy and Long-term Safety of Oral Ozanimod in Chinese Participants With Moderately to Severely Active Ulcerative Colitis (UC)

Clinical trial NCT05644665 · TERMINATED

Trial details

NCT number: NCT05644665
Sponsor: Bristol-Myers Squibb
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Ulcerative Colitis

Start date: 2022-12-09
Primary completion: 2025-03-07
Enrollment: 131

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.